Advanced Enzyme Technologies Limited Bombay S.E.

ADVENZYMES

INE837H01020

Specialty Chemicals

Market Closed - Bombay S.E. Other stock markets 03:30:52 16/07/2024 pm IST			5-day change	1st Jan Change
375.7 ^INR	-0.46%		-4.22%	+0.12%

15/05	Transcript : Advanced Enzyme Technologies Limited, Q4 2024 Earnings Call, May 15, 2024
11/05	Advanced Enzyme Technologies Limited Declares an Interim Dividend for the Financial Year 2024-2025, Payable on or Before June 5, 2024	CI

Advanced Enzyme Technologies Limited Announces Demise of Vilas Aurangabadkar, Independent Director

January 27, 2022 at 08:03 pm IST

Advanced Enzyme Technologies Limited announces demise of Vilas Aurangabadkar, Independent Director of the Company on January 27, 2022.

Latest news about Advanced Enzyme Technologies Limited

Transcript : Advanced Enzyme Technologies Limited, Q4 2024 Earnings Call, May 15, 2024	15/05
Advanced Enzyme Technologies Limited Declares an Interim Dividend for the Financial Year 2024-2025, Payable on or Before June 5, 2024	11/05	CI
Advanced Enzyme Technologies Limited Recommends Final Dividend for the Financial Year 2023-2024	11/05	CI
Advanced Enzyme Technologies Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	11/05	CI
Advanced Enzyme Technologies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	11/05	CI
Advanced Enzyme Technologies Limited Announces Cessation of Kedar J. Desai as Independent Director	30/03	CI
Advanced Enzyme Completes Acquisition of Additional 5.9% Stake in Subsidiary JC Biotech	06/03	MT
Advanced Enzyme Technologies Limited acquired additional 5.89% stake in Jc Biotech Private Limited for INR 56.1 million	05/03	CI
Transcript : Advanced Enzyme Technologies Limited, Q3 2024 Earnings Call, Feb 16, 2024	16/02
Advanced Enzyme Technologies to Lift Stake in JC Biotech to Nearly 96%	12/02	MT
Advanced Enzyme Technologies Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	10/02	CI
Advanced Enzyme Technologies Limited agreed to acquire additional 5.89% stake in Jc Biotech Private Limited for INR 56.1 million.	10/02	CI
Crisil Keeps A+ Rating on Advanced Enzyme Technologies' Bank Loans; Outlook Stable	03/01	MT
Transcript : Advanced Enzyme Technologies Limited, Q2 2024 Earnings Call, Nov 10, 2023	10/11
Advanced Enzyme Technologies Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	07/11	CI
Transcript : Advanced Enzyme Technologies Limited, Q1 2024 Earnings Call, Aug 16, 2023	16/23/16
Advanced Enzyme Technologies Declares Final Dividend for the Financial Year Ended March 31, 2023	12/23/12	CI
Transcript : Advanced Enzyme Technologies Limited - Shareholder/Analyst Call	12/23/12
Advanced Enzyme Technologies Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	12/23/12	CI
Advanced Enzyme Technologies Limited Proposes Dividend Payable on or After August 16, 2023	08/23/08	CI
Transcript : Advanced Enzyme Technologies Limited, Q4 2023 Earnings Call, May 15, 2023	15/23/15
Advanced Enzyme Technologies Limited Announces Board Changes	13/23/13	CI
Advanced Enzyme Technologies Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	13/23/13	CI
Advanced Enzyme Technologies Limited Recommends Final Dividend for the Financial Year 2022-23; Declares an Interim Dividend for the Financial Year 2023-24, Payable on or Before June 11, 2023	13/23/13	CI
Transcript : Advanced Enzyme Technologies Limited, Q3 2023 Earnings Call, Feb 14, 2023	14/23/14

Chart Advanced Enzyme Technologies Limited

Duration

Period

Chart Advanced Enzyme Technologies Limited

More charts

Advanced Enzyme Technologies Limited is an India-based company, engaged in manufacturing enzymes and probiotics. The Company is focused on the research and development, manufacturing, and marketing of approximately 400 products, which is developed from over 68 indigenous enzymes and probiotics. It provides solutions to various industries, such as human health care and nutrition, animal nutrition, baking, fruit, and vegetable processing, brewing, and malting, grain processing, protein modification, dairy processing, textile processing and others. It offers products and solutions for human nutrition, which include serratiopeptidase, fungal lactase, fungal lipase, and papain; animal nutrition, which include DigeGrain X, DigeGrain XL and DigeGrain M; food processing, including dairy and cheese processing and yeast processing, and non-food processing, including textiles processing, leather, and biofuels. Its oils and fats processing include oil extraction, oil refining, and others.

Sector

Specialty Chemicals

Calendar

25/07/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

376.5 INR

Average target price

470 INR

Spread / Average Target

+24.83%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Specialty Chemicals

	1st Jan change	Capi.
ECOLAB INC.	+22.67%	70.02B
SIKA AG	-4.09%	47.08B
GIVAUDAN SA	+21.04%	44.25B
FUJIFILM HOLDINGS CORPORATION	+35.36%	29.07B
EMS-CHEMIE HOLDING AG	+5.51%	18.91B
SYMRISE AG	+11.65%	17.15B
CELANESE CORPORATION	-6.12%	16.11B
POSCO FUTURE M CO., LTD.	-31.20%	14.28B
SOCIEDAD QUÍMICA Y MINERA DE CHILE S.A.	-32.02%	12.17B

Other Specialty Chemicals

Advanced Enzyme Technologies Limited Bombay S.E.

Equities

ADVENZYMES

INE837H01020

Specialty Chemicals

Advanced Enzyme Technologies Limited Announces Demise of Vilas Aurangabadkar, Independent Director

Latest news about Advanced Enzyme Technologies Limited

Chart Advanced Enzyme Technologies Limited

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Annual profits - Rate of surprise

Sector Other Specialty Chemicals